GlassScriptPhysician profile
Mika M King
NPI 1053311563
$9,281.83
in general payments reported to CMS, 2019-2025
19 companies · $94.60 in 2025
The $94.60 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $312 · 2020: $149 · 2021: $98.09 · 2022: $8,493 · 2023: $115 · 2024: $19.55 · 2025: $94.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $129 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $129.09 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,435.97 | 2022 | |
| Abbvie INC. | $130.53 | 2019-2022 | |
| Astellas Pharma US INC | $99.99 | 2023 | |
| Pfizer INC. | $99.57 | 2019-2022 | |
| Avion Pharmaceuticals | $99.53 | 2020-2023 | Balcoltra |
| Coopersurgical, INC. | $61.63 | 2020-2025 | Ally II Ups |
| Bayer Healthcare Pharmaceuticals INC. | $49.89 | 2019-2025 | |
| Vertical Pharmaceuticals, LLC | $49.82 | 2019-2020 | |
| Millicent US INC | $49.67 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Daiichi Sankyo INC. | $44.68 | 2019-2020 | |
| Amgen INC. | $28.88 | 2019 | |
| Evofem Biosciences, INC. | $24.75 | 2021 | |
| Next Science LLC | $21.59 | 2020 | |
| Myovant Sciences INC. | $17.25 | 2021 | |
| Hologic Sales and Service, LLC | $15.45 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.51 | 2019 | |
| Exeltis, USA INC. | $13.94 | 2021 | |
| Lupin INC. | $12.59 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mika King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.